Please pass the chips: Genomic insights into obesity and diabetes

Journal of Nutrition

Volumn 131, Issue 8, 2001, Pages 2078-2081

  Nadler, S T ^a   Attie, A D ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Adipose tissue; Diabetes; Gene expression; Obesity

Indexed keywords

INSULIN;

ADIPOSE TISSUE; CARBOHYDRATE METABOLISM; DNA MICROARRAY; GENE EXPRESSION; HYPERGLYCEMIA; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MUSCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PATHOGENESIS; REVIEW; RISK FACTOR;

EID: 0034900072     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/131.8.2078     Document Type: Review

References (40)

1. Adipogenesis and obesity: Rounding out the big picture
2. Physiologic actions of insulin
3. Potential mechanism of insulin action on glucose transport in the isolated rat adipose cell. Apparent translocation of intracellular transport systems to the plasma membrane
4. Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site
5. Leptin: The tale of an obesity gene
6. Obese and diabetes: Two mutant genes causing diabetes-obesity syndromes in mice
7. Congenital leptin deficiency is associated with severe early-onset obesity in humans
8. Regulation of fatty acid homeostasis in cells: Novel role of leptin
9. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance
10. AdipoQ is a novel adipose-specific gene dysregulated in obesity
11. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients
12. The hormone resistin links obesity to diabetes
13. Positional cloning of the mouse obese gene and its human homologue
14. Genetic obesity unmasks epistatic control of type 2 diabetes susceptibility
15. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: Model for congenital generalized lipodystrophy
16. Life without white fat: A transgenic mouse
17. Troglitazone action is independent of adipose tissue
18. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver
19. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy
20. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C
21. An established preadipose cell line and its differentiation in culture II. Factors affecting the adipose conversion
22. Transcriptional regulation of gene expression during adipocyte differentiation
23. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation
24. Expression profiling using cDNA microarrays
25. High density synthetic oligonucleotide arrays
26. Cellular gene expression altered by human cytomegalovirus: Global monitoring with oligonucleotide arrays
27. Gene-expression profile of the ageing brain in mice
28. Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring
29. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
30. Interpreting patterns of gene expression with self-organizing maps: Methods and application to hematopoietic differentiation
31. Cluster analysis and display of genome-wide expression patterns
32. The expression of adipogenic genesis decreased in obesity and diabetes mellitus
33. Leptin-specific patterns of gene expression in white adipose tissue
34. Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus
35. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice
36. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats
37. Thiazolidinediones: An update
38. Failure of adipocyte differentiation causes type II diabetes mellitus?
39. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones
40. Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes